Search - tctmd.com

Displaying 401 - 420 of 555

Sort: Relevancy | Date

News Daily News

Los Resultados Inmediatos y a Medio Plazo son Esperanzadores para los Andamiajes Bioabsorbibles en el Manejo de STEMI

Todd Neale

November 17, 2014

News Daily News

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Todd Neale

November 17, 2014

News Daily News

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

November 06, 2014

News Daily News

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

November 06, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Update: The EXTEND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Alexandre Abizaid

September 16, 2014

Presentation TCT 2014

Update: The Absorb ASSURE Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Thomas Schmitz

September 16, 2014

Presentation TCT 2014

Update: The Absorb GHOST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Corrado Tamburino

September 16, 2014

Presentation TCT 2014

Update: The Absorb FIRST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Christoph K. Naber

September 16, 2014

Presentation TCT 2014

Update: The Absorb EXPAND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns

September 16, 2014

Presentation TCT 2014

Featured Lecture: ABSORB II: What Has the Randomized Trial Taught us Beyond the Registries?

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Patrick W. Serruys

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Presenter: John Ormiston

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

Presentation TCT 2014

TCT 614: Detailed Morphologic Characterization of the Strut Composition Following Absorb Scaffold Placement in a Porcine Coronary Artery Model Through 48 Months

Presenter: David P. Faxon, Fumiyuki Otsuka, MD

September 15, 2014

Advertisement

Los Resultados Inmediatos y a Medio Plazo son Esperanzadores para los Andamiajes Bioabsorbibles en el Manejo de STEMI

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

Absorb III/IV: Testing Noninferiority and Superiority

Absorb III/IV: Angina and Ischemia Hypotheses

Update: The EXTEND Real-World Registry

Update: The Absorb ASSURE Real-World Registry

Update: The Absorb GHOST Real-World Registry

Update: The Absorb FIRST Real-World Registry

Update: The Absorb EXPAND Real-World Registry

Featured Lecture: ABSORB II: What Has the Randomized Trial Taught us Beyond the Registries?

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

TCT 614: Detailed Morphologic Characterization of the Strut Composition Following Absorb Scaffold Placement in a Porcine Coronary Artery Model Through 48 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content